신약의 최고매출액과 최고매출소요기간: 2001~2009년 미국 시판 신약의 매출 곡선 분석

• 영문명: Peak Sales and Time to Peak Sales of New Drugs: Sales Curve Analysis of New Drugs Launched in the U.S. from 2001 to 2009
• 발행기관: 한국보건사회약료경영학회
• 저자명: 최원석(Won-Seok Choi) 이상원(Sang-Won Lee)
• 간행물 정보: 『한국보건사회약료경영학회지』제12권 제2호, 93~98쪽, 전체 6쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2024.11.30

국문 초록

Size of peak sales and time to peak sales, which are key indicators of the commercial performance of new drugs launch, vary depending on factors such as the therapeutic area, FDA review type, drug modality, company size, and orphan drug status. Therefore, analyzing the current status and related factors of peak sales and time to peak becomes a crucial element in establishing successful commercialization strategies for new drugs. This study analyzed peak sales and time to peak sales of FDA approved drugs launched in the U.S. from 2001 to 2009. One-hundred and twenty nine drugs’ sales data are gathered from the Evaluate Pharma database and analyzed by therapeutic area, FDA review type, drug modality, company size, and orphan drug status. As a result of the analysis, the median time to peak sales for all analyzed drugs was 7 years and the median peak sales was $258 million. There was a difference in time to peak sales for each therapeutic area, but no difference was seen in other categories. Median value of peak sales was higher for ‘standard review drugs’ than ‘priority review drugs’, for ‘big pharma drugs’ than for ‘non-big pharma drugs’, and for ‘non-orphan drugs’ than ‘orphan drugs’. In particular, there was a large difference in peak sales by therapeutic area. Additionally, the sales curve is similar to the S-shaped diffusion curve proposed by Rogers (1983), confirming that the ‘Diffusion of innovations’ theory can also be applied to the pharmaceutical industry. This study is the latest research using actual sales data that standardizes the peak sales and time to peak sales of FDA approved new drugs.

목차

서 론

연구방법

연구 결과

고 찰

References

키워드

new drugs time to peak sales peak sales sales curve sales forecasting